126 related articles for article (PubMed ID: 24280140)
21. Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor [corrected] of matrix metalloproteinase-1 in myocardial infarction.
Guzel S; Serin O; Guzel EC; Buyuk B; Yılmaz G; Güvenen G
Korean J Intern Med; 2013 Mar; 28(2):165-73. PubMed ID: 23525523
[TBL] [Abstract][Full Text] [Related]
22. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
Yang YJ; Zhang X; Zhu WL; Huang Y
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
[TBL] [Abstract][Full Text] [Related]
23. Correlation between acute myocardial infarction complicated with cerebral infarction and expression levels of MMP-2 and MMP-9.
Zhou L; Kou DQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):297-302. PubMed ID: 30657570
[TBL] [Abstract][Full Text] [Related]
24. Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction.
van den Borne SW; Cleutjens JP; Hanemaaijer R; Creemers EE; Smits JF; Daemen MJ; Blankesteijn WM
Cardiovasc Pathol; 2009; 18(1):37-43. PubMed ID: 18402833
[TBL] [Abstract][Full Text] [Related]
25. Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation.
Selejan SR; Hewera L; Hohl M; Kazakov A; Ewen S; Kindermann I; Böhm M; Link A
Shock; 2017 Jul; 48(1):18-28. PubMed ID: 28608784
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
[TBL] [Abstract][Full Text] [Related]
27. Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis.
Kobusiak-Prokopowicz M; Kaaz K; Marciniak D; Karolko B; Mysiak A
Kidney Blood Press Res; 2021; 46(6):749-757. PubMed ID: 34801997
[TBL] [Abstract][Full Text] [Related]
28. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
[TBL] [Abstract][Full Text] [Related]
29. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
[TBL] [Abstract][Full Text] [Related]
30. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs.
Etoh T; Joffs C; Deschamps AM; Davis J; Dowdy K; Hendrick J; Baicu S; Mukherjee R; Manhaini M; Spinale FG
Am J Physiol Heart Circ Physiol; 2001 Sep; 281(3):H987-94. PubMed ID: 11514263
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase circulating levels, genetic polymorphisms, and susceptibility to acute myocardial infarction among patients with coronary artery disease.
Hlatky MA; Ashley E; Quertermous T; Boothroyd DB; Ridker P; Southwick A; Myers RM; Iribarren C; Fortmann SP; Go AS;
Am Heart J; 2007 Dec; 154(6):1043-51. PubMed ID: 18035073
[TBL] [Abstract][Full Text] [Related]
34. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
[TBL] [Abstract][Full Text] [Related]
35. Lower serum concentration of matrix metalloproteinase-3 in the acute stage of myocardial infarction.
Samnegård A; Silveira A; Tornvall P; Hamsten A; Ericsson CG; Eriksson P
J Intern Med; 2006 May; 259(5):530-6. PubMed ID: 16629857
[TBL] [Abstract][Full Text] [Related]
36. [Gelatinases A and B activities in the serum of patients with various coronary artery disease stages].
Radenković S; Brajović M; Konjević G; Gopcević K
Vojnosanit Pregl; 2010 Oct; 67(10):825-30. PubMed ID: 21066874
[TBL] [Abstract][Full Text] [Related]
37. [The expression and significance of activator protein-1 and matrix metalloproteinases in the human heart post acute myocardial infarction].
Xie SL; Wang JF; Nie RQ; Yuan WL; Li F; Lin YQ
Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):205-7. PubMed ID: 19576087
[TBL] [Abstract][Full Text] [Related]
38. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
39. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
[TBL] [Abstract][Full Text] [Related]
40. Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.
Fujiwara T; Matsunaga T; Kameda K; Abe N; Ono H; Higuma T; Yokoyama J; Hanada H; Osanai T; Okumura K
Heart Vessels; 2007 Sep; 22(5):303-9. PubMed ID: 17879021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
